Patent · US Active

Medicaments and methods for treating mesothelioma

US9023643B2 · kind B2 · utility

2Cited by
1References
11Claims
0Family size

Assignees

Inventors

Key dates

Filing dateOct 10, 2008
Grant dateMay 5, 2015
Priority date
Expiry dateMar 8, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2760/18434
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to the use of at least one attenuated measles virus for the manufacture of a medicament intended for treating malignant mesothelioma in an individual.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.